The RANK-RANKL axis: an opportunity for drug repurposing in cancer?
- Peters, S., Clézardin, P., Márquez-Rodas, I., Niepel, D., Gedye, C.
Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities
- Gedye, C., van der Westhuizen, A., John, T.
Are you sure you would like to clear your session, including search history and login status?